Preclinical Evaluation of 124I-Radionuclide for PET/CT Imaging System
Sitah Fahad Alanazi,
Salem Ahmed Sassi,
Ibrahim Jammaz Aljammaz and
Yousif Hassan ALmalki
Additional contact information
Sitah Fahad Alanazi: Imam Mohammad ibn Saud Islamic University (IMSIU), College of Science, Department of Physics, Saudi Arabia
Salem Ahmed Sassi: Department of Medical Physics, Prince Sultan Military Medical City, Saudi Arabia
Ibrahim Jammaz Aljammaz: Cyclotron and Radiopharmaceuticals Department, King Faisal Specialist Hospital and Research Center, Saudi Arabia
Yousif Hassan ALmalki: Cyclotron and Radiopharmaceuticals Department, King Faisal Specialist Hospital and Research Center, Saudi Arabia
Biomedical Journal of Scientific & Technical Research, 2022, vol. 42, issue 3, 33605-33614
Abstract:
124-Iodine (124I) is an attractive radionuclide in clinical and preclinical PET imaging studies with a long half-life of 4.2 days. 124I has specific physical characteristics that make it more suitable than the more conventional PET radionuclides....
Keywords: Radionuclides; Protocols; Oncology; Radioimmunotherapy; Monoclonal Antibodies; Fluorine -18; fluorodeoxyglucose; Pharmacological; Fluoro-3'-Deoxy-3'-L-Fluorothymidine; Spillover Ratios (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:
Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006749.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006749.php (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:42:y:2022:i:3:p:33605-33614
DOI: 10.26717/BJSTR.2022.42.006749
Access Statistics for this article
Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas
More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().